GLPwatch
Trials (2036)
Page 32 of 34.
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes
- Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
- A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
- A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
- A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
- Exenatide For Reducing the Reinforcing Effects of Cocaine
- Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes
- A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
- Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity
- Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
- GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
- Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
- Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes
- Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
- Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
- A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
- Sit Less, Interact and Move More (SLIMM) 2 Study
- Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- Glutide for Ending Methamphetamine
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
- Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers
- Once Weekly GLP-1 in Persons With Spinal Cord Injury
- Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
- Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- Exenatide Once-weekly as a Treatment for Multiple System Atrophy
- Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
- Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
- Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
- Exeantide in Type 2 Diabetes on Insulin
- Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment
- Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
- Replication of the LEADER Diabetes Trial in Healthcare Claims
- Safety and Efficacy of YH14617 in Diabetes Mellitus
- Trial for People With Established Type 2 Diabetes During Ramadan
- Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
- Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
- Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
- GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
- Proof of Concept Study in Patients With Short Bowel Syndrome
- a Study of JY09 in Chinese Healthy Subjects
- Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
- A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
- Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function
- Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
- RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
- The Use of Liraglutide in Brain Death
- Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
- A Study of Multiple Doses of LY3305677 in Healthy Participants
- Semaglutide vs Sitagliptin
- Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
- A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
- Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
- Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
- Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
- A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
- Incretin Therapies in Obesity-related HFpEF